Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumothorax-I01:26

Pneumothorax-I

594
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
594
Pneumothorax-II01:27

Pneumothorax-II

454
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
454
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

357
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
357
Pleura of the Lungs01:13

Pleura of the Lungs

3.7K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
3.7K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

2.3K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
2.3K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

321
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
321

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same author

Pulmonary venoocclusive disease/pulmonary capillary hemangiomatosis: Inadequacy of clinico-radiologic features in diagnosis.

Human pathology·2026
Same author

Lung Auscultation for Detecting Interstitial Lung Disease in Patients with Newly Diagnosed Systemic Sclerosis: Retrospective Cohort Study.

Diagnostics (Basel, Switzerland)·2026
Same author

Spontaneous pneumothorax-associated with genetic disorders.

Therapeutic advances in respiratory disease·2026
Same author

Pulmonary Hypertension Associated With Interstitial Lung Disease: State-of-the-Art Review.

The European respiratory journal·2026
Same author

Current diagnosis, epidemiology, and management of interstitial lung abnormalities.

Frontiers in medicine·2026
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Related Experiment Video

Updated: Oct 13, 2025

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

990

Chylothorax and Pseudochylothorax.

Cassandra M Braun1, Jay H Ryu1

  • 1Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Gonda 18 South, 200 First Street, Southwest, Rochester, MN 55905, USA.

Clinics in Chest Medicine
|November 14, 2021
PubMed
Summary
This summary is machine-generated.

Chylothorax and pseudochylothorax are rare pleural effusions that appear milky. Differentiating these conditions using pleural fluid cholesterol and triglyceride levels is crucial for appropriate diagnosis and management.

Keywords:
ChylothoraxLymphangioleiomyomatosisPseudochylothoraxYellow nail syndrome

More Related Videos

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
05:50

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure

Published on: March 12, 2020

14.0K
Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

276

Related Experiment Videos

Last Updated: Oct 13, 2025

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

990
International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
05:50

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure

Published on: March 12, 2020

14.0K
Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

276

Area of Science:

  • Pulmonology
  • Thoracic Medicine

Background:

  • Chylothorax and pseudochylothorax are rare pleural effusions.
  • Both conditions present with milky-appearing pleural fluid.
  • Distinct etiologies necessitate different management approaches.

Purpose of the Study:

  • To highlight the importance of differentiating chylothorax from pseudochylothorax.
  • To emphasize the role of pleural fluid analysis in diagnosis.
  • To guide clinical evaluation and management strategies.

Main Methods:

  • Review of clinical presentations of chylothorax and pseudochylothorax.
  • Analysis of pleural fluid biochemistry, specifically cholesterol and triglyceride levels.
  • Correlation of fluid analysis with diagnostic and management pathways.

Main Results:

  • Milky pleural effusion is a common feature of both conditions.
  • Pleural fluid cholesterol and triglyceride levels are key differentiating markers.
  • Biochemical analysis guides the distinction between chylothorax and pseudochylothorax.

Conclusions:

  • Accurate differentiation of chylothorax and pseudochylothorax is essential.
  • Pleural fluid analysis is a critical diagnostic tool.
  • Timely and accurate diagnosis leads to appropriate patient management.